PBI81 PERSISTENCE AND HEALTHCARE RESOURCE USE (HCRU) IN PATIENTS INITIATING ETANERCEPT TREATMENT FOR ANKYLOSING SPONDYLITIS (AS) OR PSORIATIC ARTHRITIS (PSA) IN GERMANY: A REAL-WORLD ANALYSIS